Triple immunosuppressive therapy in the treatment of severe ulcerative colitis;Triple terapia inmunosupresora en el tratamiento de la colitis ulcerosa grave

Gastroenterologia y Hepatologia

Volumn 27, Issue 1, 2004, Pages 1-5

  Castro, B ^a   Crespo, J ^a   Garcia Suarez C ^a   Fabrega E ^a   Casafont, F ^a   Pons Romero, F ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON RESECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; RELAPSE; REMISSION; STEROID THERAPY; TREATMENT INDICATION; ULCERATIVE COLITIS;

EID: 1142274660     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13056028     Document Type: Article

References (17)

1. Katz J. The course of inflammatory bowel disease. Med Clin North Am 1994;78:1275-80.
2. Faubion WA, Loftus EV, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population based study. Gastroenterol 2001;121:255-60.
3. Brynskov J. Cyclosporine for IBD: mechanism and possible actions. Scan J Gastroenterol 1993;28:849-57.
4. Lichtiger S, Present DH. Preliminary report cyclosporin in treatment of severe active ulcerative colitis. Lancet 1990;336: 16-9.
5. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955;2:1041-8.
6. Travis SPL, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG, et al. Predicting outcome in severe ulcerative colitis. Gut 1996;38:905-10.
7. Jalan KN, Sircus W, Card WJ, Falconer CW, Bruce CB, Crean GP, et al. An experience with ulcerative colitis: toxic dilatation in 55 cases. Gastroenterology 1969;57:68-82.
8. Sandborn WJ. Severe ulcerative colitis. Curr Treat Options Gastroenterol 1999;2:113-8.
9. Sandborn WJ. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflammatory Bowel Disease 1995; 3:48-63.
10. Lichtiger S, Present DH, Korkbluth A, Gelernt I, Baver J, GaIler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-5.
11. Stack WA, Long RG, Hawkey CJ. Short and long-term outcome of patients treated with cyclosporine for severe acute ulcerative colitis. Aliment Pharmacol Ther 1998;12:973-8.
12. Sandborn J, Tremaine WJ. Cyclosporine treatment of inflammatory bowel disease. Mayo Clin Proc 1992;67:981-90.
13. Kornbluth A, Present DH, Lichtiger S, Hanauer S. Cyclosporine for severe ulcerative colitis: a user's guide. Am J Gastroenterol 1997;92:1424-8.
14. Palestine AG, Nussenblatt RB, Chan CC. Side effects of systemic cyclosporine in patients not undergoing transplantation. Am J Med 1984;77:652-6.
15. Fernández-Bañares F, Bertrán X, Esteve-Comas M, Cabré E, Menacho M, Humbert P, et al. Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid refractory severe ulcerative colitis. Am J Gastroenterol 1996;91:2498-9.
16. Domenech E, García-Panella E, Bernal I, Rosinach M, Cabré E, Fluviá J, et al. Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid refractory ulcerative colitis. Aliment Pharmacol Ther 2002; 16:2061-5.
17. Loftus CG, Loftus EV, Sandborn WJ. Cyclosporin for refractory ulcerative colitis (Therapy update). Gut 2003;52:172-3.